The FDA is looking at shifting to a brief summary format more like that of the “Drug Facts” design used for OTC products, based on a study showing that it led to higher risk comprehension. The ...
Specification for the Asset Summary Reporting Format While this specification was developed to support the immediate needs of the security automation and the continuous monitoring communities, it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results